Order Entry
Austria
ContactUsLinkComponent
 
Human recombinant SLAMF7 (from HEK293)
 
Human recombinant SLAMF7 (from HEK293)

 

  • Protein/Peptid-Typ:
    Rekombinant
  • Ursprung:
    HEK293 cells
  • Spezies:
    Human
  • Lagerbedingungen:
    –20 °C
  • Endotoxingehalt:
    Less than 1,0 EU per μg by the LAL method.
  • Biologische Aktivität:
    Lyopilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Humanized Anti-Human CS1 MAb at 1 μg/ml (100 µl/well) can bind Biotinylated Human SLAMF7, Avitag,His Tag with a linear range of 0,6-5 ng/ml (Routinely tested).; 2e5 of Anti-SLAMF7 CAR-293 cells were stained with 100 µl of 0,1 μg/ml of Biotinylated Human SLAMF7, Avitag, His Tag and negative control protein respectively, washed and then followed by PE-SA and analyzed with FACS (QC tested).
  • Gen-ID:
    Q9NQ25-1
  • Frei von Trägern:
    Y
  • Frei von Proteasen:
    Y
  • Tierfrei:
    Y
  • Proteinsynonym:
    FOAP-12|CRACC|19A|CS1|CD319|SLAMF7
  • Protein/Peptid-Name:
    SLAMF7
  • Purity:
    >95%
  • Molecular weight:
    25,6 kDa
  • Endotoxinspiegel:
    Low
  • Zusammensetzung:
    Lyopilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before lyophilisation.
  • Frei von Nukleasen:
    Y
  • Transporttemperatur:
    Powder,RT

 

Frequently Bought Together